Atlantic Therapeutics were delighted to visit Dubai in April, to introduce Innovotherapy to several distributors from the Middle East and Asia, and to speak with clinicians during the Obs-Gyne conference about this safe, effective and clinically-proven treatment for pelvic floor weakness.
CEO Steve Atkinson was joined by Business Development Manager Misbah Jabbar, Senior Marketing Executive Aisling Donoghue and Global Product Manager Danny Forde to deliver Innovotherapy sales training to a carefully selected network of distributors from Saudi Arabia, Qatar, Oman, Bahrain, Sri Lanka, India, and the Lebanon. The training focused on the clinical research supporting Innovotherapy as a conservative intervention for the treatment of stress urinary incontinence, on the very positive feedback received from clinicians and patients about Innovotherapy, and on the recent investment received by Atlantic Therapeutics to support the company’s growth and development. All distributors remarked on the prevalence of pelvic floor weakness in their regions, and there is a clear demand from clinicians for a new treatment option for this debilitating condition. Clare Roche, Market Adviser with Enterprise Ireland, joined the afternoon session to discuss the growing impact of Irish medical devices companies in the Middle East and around the globe.
Atlantic Therapeutics then attended Exhibition and Congress held at Dubai World Trade Centre, the region’s largest gathering of obstetricians and gynecologists, speaking directly with clinicians about Innovotherapy and where it should be positioned in the care pathway. The Atlantic Therapeutics stand attracted large numbers of visitors, with clinicians particularly interested in the non-invasive delivery of the treatment. Our distributors were on hand to field questions from clinicians in their regions, and CEO Steve Atkinson spoke with the conference organizers about Innovotherapy and the potential impact of this pioneering technology for this region. The conference was held over three days with the Atlantic Therapeutics stand proving to be one of the most popular during the event, affording us the opportunity to open discussions with potential distributors from the UAE, Kuwait and Iran.
Atlantic Therapeutics’ vision is to enable millions of people each year to restore their pelvic floor and thereby restore their control, confidence and active lifestyle. Thousands of clinicians and customers rely on INNOVO every day, and our products improve many thousands of lives every year. We are committed to introducing Innovotherapy across the globe, giving women and men everywhere the opportunity to treat the underlying cause of stress urinary incontinence, rather than simply managing the problem. We look forward to the opportunity to grow and develop our relationships with our new distributors and to providing clinicians in these markets with a safe, effective and clinically proven treatment option.